Matthew L. MacDonald

2.7k total citations
44 papers, 1.7k citations indexed

About

Matthew L. MacDonald is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Matthew L. MacDonald has authored 44 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Cellular and Molecular Neuroscience, 21 papers in Molecular Biology and 10 papers in Physiology. Recurrent topics in Matthew L. MacDonald's work include Neuroscience and Neuropharmacology Research (21 papers), Alzheimer's disease research and treatments (10 papers) and Tryptophan and brain disorders (7 papers). Matthew L. MacDonald is often cited by papers focused on Neuroscience and Neuropharmacology Research (21 papers), Alzheimer's disease research and treatments (10 papers) and Tryptophan and brain disorders (7 papers). Matthew L. MacDonald collaborates with scholars based in United States, Japan and Denmark. Matthew L. MacDonald's co-authors include Christine Konradi, Robert A. Sweet, Molly E. Eaton, Stephan Heckers, John P. Walsh, Francine M. Beneš, Daniel Elswick, Wei Hu, Alipi V. Naydenov and David A. Lewis and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Matthew L. MacDonald

41 papers receiving 1.7k citations

Peers

Countries citing papers authored by Matthew L. MacDonald

Since Specialization

Citations

This map shows the geographic impact of Matthew L. MacDonald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew L. MacDonald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew L. MacDonald more than expected).

Fields of papers citing papers by Matthew L. MacDonald

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew L. MacDonald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew L. MacDonald. The network helps show where Matthew L. MacDonald may publish in the future.

Co-authorship network of co-authors of Matthew L. MacDonald

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew L. MacDonald. A scholar is included among the top collaborators of Matthew L. MacDonald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew L. MacDonald. Matthew L. MacDonald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Deciphering the alteration of MAP2 interactome caused by a schizophrenia-associated phosphorylation 2024 ·Neurobiology of Disease ·Jun Lyu, Matthew L. MacDonald, Sara Ruiz, S. M. Chou, (unknown), Stephen L. Buchwald, Melanie Grubisha, Robert A. Sweet	1
2	The expression system influences stability, maturation efficiency, and oligomeric properties of the potassium-chloride co-transporter KCC2 2024 ·Neurochemistry International ·(unknown), (unknown), Cassandra Happe, Matthew L. MacDonald, Elias Aizenman, Jeffrey L. Brodsky	3
3	Impacts of CACNB4 overexpression on dendritic spine density in both sexes and relevance to schizophrenia 2024 ·Translational Psychiatry ·Emily M. Parker, (unknown), (unknown), (unknown), (unknown), Claire E. J. Cheetham, Matthew L. MacDonald, (unknown), (unknown), Robert A. Sweet	1
4	Circadian rhythm disruptions associated with opioid use disorder in synaptic proteomes of human dorsolateral prefrontal cortex and nucleus accumbens 2023 ·Molecular Psychiatry ·Stéphanie Puig, Xiangning Xue, (unknown), Micah A. Shelton, (unknown), Mariah A. Hildebrand, Jill R. Glausier, Zachary Freyberg, George C. Tseng, Anastasia K. Yocum, David A. Lewis, Marianne L. Seney, Matthew L. MacDonald, Ryan W. Logan	7
5	Inhibitory and excitatory synaptic neuroadaptations in the diazepam tolerant brain 2023 ·Neurobiology of Disease ·(unknown), Nadya Povysheva, Caitlyn A. Chapman, Matthew L. MacDonald, Marco Fazzari, (unknown), (unknown), (unknown), (unknown), Katarina Vajn, (unknown), Susan T. Weintraub, Jon W. Johnson, Tija C. Jacob	7
6	G protein‐biased GPR3 signaling induces glial activation and ameliorates amyloid pathology in a preclinical Alzheimer’s disease mouse model 2023 ·Alzheimer s & Dementia ·Amantha Thathiah, Yunhong Huang, (unknown), (unknown), Carolyn Ferguson, (unknown), (unknown), (unknown), Bryan Hurtle, Takashi Saito, Takaomi C. Saido, Matthew L. MacDonald, Sean P. Farris, Gregg E. Homanics	0
7	Targeting the post-synaptic proteome has therapeutic potential for psychosis in Alzheimer Disease 2023 ·Communications Biology ·(unknown), Michael R. DeChellis-Marks, Li Zeng, Ping Yu Fan, Oscar L. López, Ying Ding, Lirong Wang, Julia Kofler, Matthew L. MacDonald, Robert A. Sweet	6
8	G protein–biased GPR3 signaling ameliorates amyloid pathology in a preclinical Alzheimer’s disease mouse model 2022 ·Proceedings of the National Academy of Sciences ·Yunhong Huang, (unknown), (unknown), Carolyn Ferguson, (unknown), (unknown), (unknown), Bryan Hurtle, Takashi Saito, Takaomi C. Saido, Matthew L. MacDonald, Gregg E. Homanics, Amantha Thathiah	22
9	GPCR kinases generate an APH1A phosphorylation barcode to regulate amyloid-β generation 2022 ·Cell Reports ·(unknown), Yunhong Huang, Ji Young Lee, Pemra Doruker, James Krieger, (unknown), Matthew L. MacDonald, İvet Bahar, Amantha Thathiah	4
10	Psychosis in Alzheimer's Disease Is Associated With Increased Excitatory Neuron Vulnerability and Post-transcriptional Mechanisms Altering Synaptic Protein Levels 2022 ·Frontiers in Neurology ·Michael R. DeChellis-Marks, Yue Wei, Ying Ding, Cody M. Wolfe, (unknown), Matthew L. MacDonald, Oscar L. López, Robert A. Sweet, Julia Kofler	8
11	Cell-type and subcellular compartment-specific APEX2 proximity labeling reveals activity-dependent nuclear proteome dynamics in the striatum 2021 ·Nature Communications ·Vasin Dumrongprechachan, (unknown), (unknown), Manish Kumar, Matthew L. MacDonald, Yevgenia Kozorovitskiy	44
12	Phosphoproteomic analysis of cocaine memory extinction and reconsolidation in the nucleus accumbens 2018 ·Psychopharmacology ·Mary M. Torregrossa, Matthew L. MacDonald, Kathryn L. Stone, TuKiet T. Lam, Angus C. Nairn, Jane R. Taylor	10
13	Laser capture microdissection–targeted mass spectrometry: a method for multiplexed protein quantification within individual layers of the cerebral cortex 2018 ·Neuropsychopharmacology ·Matthew L. MacDonald, (unknown), (unknown), Zhe Sun, Dominique Arion, Ying Ding, Nathan A. Yates, Robert A. Sweet, David A. Lewis	12
14	Loss of Microtubule-Associated Protein 2 Immunoreactivity Linked to Dendritic Spine Loss in Schizophrenia 2015 ·Biological Psychiatry ·Micah A. Shelton, Jason T. Newman, Hong Gu, Allan R. Sampson, Kenneth N. Fish, Matthew L. MacDonald, (unknown), (unknown), Karl‐Anton Dorph‐Petersen, Peter Penzes, David A. Lewis, Robert A. Sweet	84
15	Altered Glutamate Protein Co-Expression Network Topology Linked to Spine Loss in the Auditory Cortex of Schizophrenia 2014 ·Biological Psychiatry ·Matthew L. MacDonald, Ying Ding, Jason T. Newman, Scott E. Hemby, Peter Penzes, David A. Lewis, Nathan A. Yates, Robert A. Sweet	53
16	Biochemical Fractionation and Stable Isotope Dilution Liquid Chromatography-mass Spectrometry for Targeted and Microdomain-specific Protein Quantification in Human Postmortem Brain Tissue 2012 ·Molecular & Cellular Proteomics ·Matthew L. MacDonald, Eugene Ciccimaro, Amol Prakash, Anamika Banerjee, Steven H. Seeholzer, Ian A. Blair, Chang-Gyu Hahn	26
17	Isolation rearing and hyperlocomotion are associated with reduced immediate early gene expression levels in the medial prefrontal cortex 2007 ·Neuroscience ·John B. Levine, (unknown), Matthew L. MacDonald, (unknown), (unknown), François Berthiaume, Christine Konradi	62
18	Decrease in creatine kinase messenger RNA expression in the hippocampus and dorsolateral prefrontal cortex in bipolar disorder 2006 ·Bipolar Disorders ·Matthew L. MacDonald, Alipi V. Naydenov, (unknown), David Matzilevich, Christine Konradi	69
19	Antipsychotic drugs elevate mRNA levels of presynaptic proteins in the frontal cortex of the rat 2005 ·Biological Psychiatry ·Matthew L. MacDonald, Molly E. Eaton, Joshua T. Dudman, Christine Konradi	69
20	Molecular Evidence for Mitochondrial Dysfunction in Bipolar Disorder 2004 ·Archives of General Psychiatry ·Christine Konradi, Molly E. Eaton, Matthew L. MacDonald, John P. Walsh, Francine M. Beneš, Stephan Heckers	396

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact